Advertisement
Mergers and Acquisitions
Subscribe to Mergers and Acquisitions

The Lead

Ritter Pharmaceuticals, Inc. announces closing of $20,000,000 IPO

July 1, 2015 7:59 am | by BUSINESS WIRE | News | Comments

Ritter Pharmaceuticals, Inc., a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases with its lead product, RP-G28, being developed for the treatment of lactose intolerance ...

Allergan purchasing Kythera Biopharmaceuticals for $2.1 billion

June 18, 2015 12:38 pm | News | Comments

In recent news, Allergan will be purchasing Kythera Biopharmaceuticals for $2.1 billion. With...

Tribute Pharmaceuticals acquires Medical Futures

June 17, 2015 11:36 am | News | Comments

The acquisition further diversifies Tribute's product portfolio in Canada through the addition...

Actavis changes name

June 15, 2015 11:51 am | News | Comments

The combination of Allergan and Actavis created one of the world's top 10 pharmaceutical...

View Sample

FREE Email Newsletter

Target selling pharmacy, clinic businesses to CVS Health

June 15, 2015 11:33 am | by TOM MURPHY, AP Business Writer | News | Comments

Target will sell its pharmacy and clinic businesses to the drugstore chain for about $1.9 billion in a deal that combines the resources of two retailers seeking to polish their health care reputations.

Cardinal acquires Harvard Drug Group for $1.1B

June 8, 2015 11:35 am | by Cardinal Health | News | Comments

Cardinal Health will use existing cash and new debt to purchase the distributor.

Perrigo to acquire GSK OTC brands

June 2, 2015 12:27 pm | by PR Newswire | News | Comments

Perrigo will acquire a portfolio of well-established over-the-counter brands from GlaxoSmithKline Consumer Healthcare.

Advertisement

Lannett completes acquisition of Silarx

June 2, 2015 12:19 pm | by PR Newswire | News | Comments

Lannett Company announced that it has completed the acquisition of privately held Silarx Pharmaceuticals - a manufacturer and marketer of liquid generic pharmaceutical products. 

Zimmer one step closer to Biomet merger

May 29, 2015 11:11 am | by PRNewswire | News | Comments

Zimmer Holdings, Inc. announced today that it has finalized agreements with buyers to divest in the United States certain Zimmer Unicompartmental High-Flex Knee System assets, Biomet Discovery Elbow System assets and CobaltT bone cement assets.

Zimmer one step closer to Biomet merger

May 29, 2015 11:11 am | by PRNewswire | News | Comments

Zimmer Holdings announced that it has finalized agreements with buyers to divest their own assets, as well as those of Biomet and Cobalt.

Abbvie completes $21 billion buyout of Pharmacyclics

May 27, 2015 10:47 am | by AP | News | Comments

The buyout adds another major revenue producer to Abbvie's portfolio, which already includes the world's top-selling drug, Humira.

AbbVie completes acquisition of Pharmacyclics

May 26, 2015 10:55 am | by PRNewswire | News | Comments

"The companies' shared expertise, combined with AbbVie's broad late-stage oncology pipeline, has the potential to transform the cancer treatment landscape for hematological malignancies and improve patient outcomes and quality of life," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. 

Advertisement

Chinese consortium to jointly acquire U.S. biotechnology company Ambrx

May 22, 2015 9:42 am | by PRNewswire | News | Comments

A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund ("CEL Healthcare Fund"), and WuXi PharmaTech announced today that the Consortium ...

Tribute Pharmaceuticals announces expansion into U.S. market

May 21, 2015 4:21 pm | by Associated Press | News | Comments

Tribute Pharmaceuticals Canada Inc., a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., is pleased to announce that its wholly owned subsidiary ...

Achillion shares sink after partnering with Johnson & Johnson

May 21, 2015 11:56 am | by TOM MURPHY, AP Business Writer | News | Comments

Investors started shedding Achillion shares early Wednesday, less than a day after the drugmaker announced a partnership with pharmaceutical giant Johnson & Johnson that snuffed out the prospect of a near-term acquisition. Achillion and Johnson & Johnson's Janssen Pharmaceutical Companies ...

CVS to Acquire Drug Distributor Omnicare for $10.4 B

May 21, 2015 11:34 am | by TOM MURPHY, AP Business Writer | News | Comments

CVS Health will spend more than $10 billion to buy pharmacy services provider Omnicare and tap a growing target for prescription drug distribution: care for the elderly. The deal announced Thursday will give one of the nation's biggest pharmacy benefits ...

Endo’s Purchase of Par Pharma Shakes up the Industry

May 21, 2015 11:03 am | News | Comments

US Pharma M&A activity has yet to show any signs of a slowdown after the $8.1bn exit of Par Pharma by TPG to Endo was announced on Monday. The US Pharma industry has seen 39 deals valued at US$ 77.3bn to-date, three more deals announced ...

Advertisement

Boehringer Makes Phase 1 Acquisition

May 18, 2015 1:21 pm | by Associated Press | News | Comments

Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has exercised its option and acquired the investigational drug PXS4728A, to develop it for the treatment of the liver-related condition NASH and ...

Endo Buying Par Pharma In Generics Push

May 18, 2015 1:15 pm | by Associated Press | News | Comments

Endo International will spend about $8.05 billion to acquire Par Pharmaceutical as it pushes further into the generic drug market. Endo CEO Rajiv De Silva said the deal make Endo one of the top five generics companies as measured by U.S. sales.

FTC Seeks More Info From Pfizer About Hospira Acquisition

May 15, 2015 12:04 pm | by Pfizer Inc. | News | Comments

Pfizer Inc. today announced that it has received a request for additional information from the FTC with respect to its previously announced proposed acquisition of Hospira.

Eli Lilly, Sanford-Burnham Announce Collaboration

May 14, 2015 12:00 pm | by Eli Lilly and Company | News | Comments

Eli Lilly and Company and Sanford-Burnham Medical Research Institute today announced that they will collaborate to discover and develop immunological therapies.

ProPharma Group Acquires PROSAR

May 14, 2015 11:21 am | by ProPharma Group | News | Comments

ProPharma Group, a  compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.

Pfizer Acquires Minority Interest in AM-Pharma

May 12, 2015 11:41 am | by Pfizer | News | Comments

Pfizer recently announced their acquisition of a minority equity interest in AM-Pharma, and secured an exclusive option to acquire the remaining equity in the company.

Juno Acquires Stage Cell

May 12, 2015 11:15 am | by Juno Therapeutics | News | Comments

Juno Therapeutics, a biopharmaceutical company focused on cancer treatment, announced today that it has acquired Stage Cell Therapeutics GmbH.

Endo Acquires Portfolio of Branded and Generic Products

May 11, 2015 11:06 am | by Endo International | News | Comments

Endo International has acquired a broad portfolio of branded and generic injectable and established products focused on pain, anti-infectives, cardiovascular and other specialty therapeutics areas.

BASF Sells Part of Its Pharma Business

May 11, 2015 10:20 am | by Andy Szal, Digital Reporter | News | Comments

BASF recently announced plans to sell several prominent pharmaceutical ingredients to Siegfried Holding AG for $306 million.

Pharmaceuticals, Life Sciences Show Dramatic Jump in Merger Activity

May 8, 2015 11:15 am | by Andy Szal, Digital Reporter | News | Comments

The pharmaceuticals and life sciences sectors saw 35 mergers and acquisitions worth $166.3 billion in the first three months of 2015, a value that eclipsed transactions from all of 2014.

MorphoSys Acquires Lanthio Pharma

May 7, 2015 11:16 am | by MorphoSys AG | News | Comments

MorphoSys AG announced today that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V.

Alexion Pharma to Pay $8.4 Billion for Synageva BioPharma

May 6, 2015 11:14 am | by Tom Murphy, AP Business Writer | News | Comments

Alexion Pharmaceuticals will pay a huge premium to buy fellow rare disease treatment maker Synageva BioPharma in an $8.4-billion deal for a company with no products on the market.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading